Pandemic threat? Anyone else concerned?

Right, after all, the idea IS to kill off all of us useless eaters that have been forced to pay into the system all of our lives...

 
All studies prior to Covid were saying they don't really work.
But Leftist are excellent pr deception strategist. They were thinking about the narrative beforehand knowing that Trump would go with prior studies.
"Believe Science" was the leftist mantra, all the while ignoring previous Scientific studies.
Even on this thread we have had a few naive leftist heralding the mask narrative.
You know what is also ironic, is Science is what made this virus in the first place. "Follow the Science", LMAO, The Science is actually following us and has murdered 4 million plus people, So Far... :mad:
 
I cannot emphasize strongly enough that you should share this link, this video. Listen to this patriotic Canuck and his story. It’s how we defeat these blithering idiots. Force them to show their cards, of which they have NONE.

Love how he called Mask an Ineffective Face Diaper, hahahaha I am going to start telling people how good they look with diaper's on their faces, hahahaha
It kind of fits the narrative of today with all of the crap that comes out of people's mouths repeating the stupidity of MSM, LMAO...
 
Nothing to see here... Might have been posted before but I'm just seeing this.

So this is the response from Pfizer??? Unrelated??? This lady became paralyzed below the neck less than 24 hours after taking the second dose of the Pfizer shot!!!
Wow, how sad, Pfizer don't care they are fully protected against any lawsuits anyway...


1628517368759.png
1628517334529.png
 
Wow, how sad, Pfizer don't care they are fully protected against any lawsuits anyway...

For some reason pfizer/biontech was able to convince the european union that they are responsible for ANY risk and pay ANY resulting costs. So in my opinion its just another fact that there are may problems in future which they dont know about because their vaccine was not tested like normal meds.
 
From Google translate:

The Mainz biopharmaceutical company Biontech is reaping the fruits of its vaccine efforts. In the quarter from April to June, profits rose to 2.7 billion euros, the company announced in an online presentation on Monday.

The entire amount is due to payments made for those of the company; The US partner Pfizer recorded a large part of this in the USA. In the previous year there was still a loss due to research expenditure and the absence of marketable products. Sales climbed to 5.3 billion euros, which suggests a very decent profit margin with the vaccine.

Biontech sets a record in the pharmaceutical industry
The current billion-dollar profit is just the beginning. With the orders for Covid vaccinations it has received so far, Biontech expects sales of 15.9 billion euros. It is the largest bundle of orders for a single drug in the history of the pharmaceutical industry.

Vaccine manufacturer Biontech rejects allegations
The company's insistence on the third vaccination also arouses suspicion: three instead of two doses for a large part of the population, that also means a third more sales for the providers. Since Biontech also insists that the complete vaccination provides good protection against Delta, profit interests could be in the foreground here.

Biontech, however, rejects this interpretation. The company gives scientific reasons for the refreshment: In both older and younger study participants, the number of antibodies already decreased significantly half a year after the full vaccination. In the over 65s it even fell below the detection limit. "For these target groups, we recommend a third dose seven to nine months after the second dose as a booster," said Co-Chef Özlem Türeci.

Biontech plans to apply for approval for the refresher soon. The company is preparing to develop its own active ingredient against Delta, but considers the existing product to be completely sufficient. It may not always protect against infection, but according to Türeci it almost always prevents a severe course - even with Delta.

The EU Commission has ordered 900 million doses from Biontech in order to be able to vaccinate Europeans a third time if necessary. There is also an option for a further 900 million cans. With a recently increased price of 19.50 euros per dose, that means a payment of 35 billion euros in purely mathematical terms.
 
From Google translate:

The Mainz biopharmaceutical company Biontech is reaping the fruits of its vaccine efforts. In the quarter from April to June, profits rose to 2.7 billion euros, the company announced in an online presentation on Monday.

The entire amount is due to payments made for those of the company; The US partner Pfizer recorded a large part of this in the USA. In the previous year there was still a loss due to research expenditure and the absence of marketable products. Sales climbed to 5.3 billion euros, which suggests a very decent profit margin with the vaccine.

Biontech sets a record in the pharmaceutical industry
The current billion-dollar profit is just the beginning. With the orders for Covid vaccinations it has received so far, Biontech expects sales of 15.9 billion euros. It is the largest bundle of orders for a single drug in the history of the pharmaceutical industry.

Vaccine manufacturer Biontech rejects allegations
The company's insistence on the third vaccination also arouses suspicion: three instead of two doses for a large part of the population, that also means a third more sales for the providers. Since Biontech also insists that the complete vaccination provides good protection against Delta, profit interests could be in the foreground here.

Biontech, however, rejects this interpretation. The company gives scientific reasons for the refreshment: In both older and younger study participants, the number of antibodies already decreased significantly half a year after the full vaccination. In the over 65s it even fell below the detection limit. "For these target groups, we recommend a third dose seven to nine months after the second dose as a booster," said Co-Chef Özlem Türeci.

Biontech plans to apply for approval for the refresher soon. The company is preparing to develop its own active ingredient against Delta, but considers the existing product to be completely sufficient. It may not always protect against infection, but according to Türeci it almost always prevents a severe course - even with Delta.

The EU Commission has ordered 900 million doses from Biontech in order to be able to vaccinate Europeans a third time if necessary. There is also an option for a further 900 million cans. With a recently increased price of 19.50 euros per dose, that means a payment of 35 billion euros in purely mathematical terms.
Last year no Vaccines, 99.7% survival rate, this year after Vaccines 99.8% or even 99.9% survival rate, hmmm. So glad Big Pharma care so much about all us old people, got to keep us alive to push all their other drugs on us, we are their biggest customers...LMAO
Where would we be without them, Heaven??? LOL
 
A new Pfizer funded study of 45,000 patients conducted over 6 months found there were 15 deaths in the vaccinated people versus 14 deaths in the unvaccinated

The highly-anticipated Pfizer’s safety and efficacy study of the BNT162b2 mRNA COVID-19 vaccine is finally out. After six months of monitoring over 45,000 patients, the study found that there were 15 deaths in the vaccine group and 14 deaths in the unvaccinated placebo group. In other words, more vaccinated people died from the virus than the unvaccinated. According to the study, there were no deaths among 12‒15-year-old participants. The study not only demonstrates the lack of efficacy in the most important group but also highlights the extremely low fatality rate of Covid-19 in most of the 45,000 participants.

A new Pfizer funded study of 45,000 patients conducted over 6 months found there were 15 deaths in the vaccinated people versus 14 deaths in the unvaccinated | Tech News | Startups News (techstartups.com)